General Biologicals Corporation (TPEX:4117)

Taiwan · Delayed Price · Currency is TWD

8.36

-0.13 (-1.53%)

Sep 30, 2026, 1:50 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Lease Management	29.81M	-	-	-	-
Protein New Drug	54.68M	34.34M	34.14M	26.76M	-
Adjustment and Elimination	-15.16M	-8.12M	-60.29M	-44.57M	-27.44M
Diagnostic Reagents	102.90M	155.46M	132.69M	258.54M	396.24M
Medical Technology	43.51M	70.24M	158.27M	129.73M	182.85M
Total	215.74M	251.93M	264.83M	370.46M	551.66M

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Asia and Others (Apart from Taiwan)	-	-	-	-	223.98M
Taiwan	124.10M	93.78M	174.86M	228.94M	189.23M
America	-	-	-	-	151.84M
Europe	21.35M	1.77M	1.80M	3.58M	4.97M
Asia (Excluding Taiwan)	3.91M	29.38M	42.62M	55.51M	-
North America	65.18M	126.71M	42.69M	77.11M	-
Other	1.20M	296.00K	2.86M	5.32M	-
Africa	-	-	-	-	9.08M
Internal Department Transaction Revenue	-	-	-	-	-27.44M
Total	215.74M	251.93M	264.83M	370.46M	551.66M